Sort   by:  
 Page size 
UnknownUse of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.
Not available
S-EPMC5782881 | biostudies-literature
UnknownHighly Sensitive and Ultra-Responsive Humidity Sensors Based on Graphene Oxide Active Layers and High Surface Area Laser-Induced Graphene Electrodes.
Not available
S-EPMC9370464 | biostudies-literature
UnknownEffects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
Not available
S-EPMC7615591 | biostudies-literature
TranscriptomicsPorphyromonas gingivalis investigated by RNA-Seq
Comparison of transcriptomes for wild-type and the following mutants: LuxS, GppX, cdhR Four conditions are compared with at least two replicates for each
ORGANISM(S): Porphyromonas gingivalis 
2012-12-01 | E-GEOD-34212 | biostudies-arrayexpress
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownAbatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
Not available
S-EPMC11046337 | biostudies-literature
UnknownAbatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Not available
S-EPMC10334296 | biostudies-literature
UnknownFrequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.
Not available
S-EPMC5714507 | biostudies-literature
UnknownImpact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
Not available
S-EPMC7618536 | biostudies-literature
UnknownActive symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.
Not available
S-EPMC2431123 | biostudies-literature
Sort   by:  
 Page size